Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Fahima Danesh Pouya, Yousef Rasmi, Irem Yalim Camci, Yusuf Tutar & Mohadeseh Nemati. (2021) Performance of capecitabine in novel combination therapies in colorectal cancer. Journal of Chemotherapy 33:6, pages 375-389.
Read now
Read now
Yahua Wang, Xue Ying, Haolun Xu, Helu Yan, Xia Li & Hui Tang. (2017) The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. International Journal of Nanomedicine 12, pages 1369-1384.
Read now
Read now
Bin Zhang, Xi Li, Bin Li, Chunmei Gao & Yuyang Jiang. (2014) Acridine and its derivatives: a patent review (2009 – 2013). Expert Opinion on Therapeutic Patents 24:6, pages 647-664.
Read now
Read now
Maiara Cássia Pigatto, Flávia De Toni Uchôa, Bruna Torres, Sandra Haas, Maria do Carmo Alves de Lima, Suely Lins Galdino, Ivan da Rocha Pitta, Norberto Peporine Lopes & Teresa Dalla Costa. (2012) Pre-clinical pharmacokinetics of the acridine antitumour candidate AC04 and its 1-oxo-metabolite plasma profile. Xenobiotica 42:7, pages 701-707.
Read now
Read now
Antonio Macchiarulo, Nicola Giacchè, Francesca Mancini, Efisio Puxeddu, Fabiola Moretti & Roberto Pellicciari. (2011) Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?. Expert Opinion on Therapeutic Patents 21:3, pages 287-294.
Read now
Read now
H. Sone, H. Akanuma & T. Fukuda. (2010) Oxygenomics in environmental stress. Redox Report 15:3, pages 98-114.
Read now
Read now
Philippe Belmont & Ismet Dorange. (2008) Acridine/acridone: a simple scaffold with a wide range of application in oncology. Expert Opinion on Therapeutic Patents 18:11, pages 1211-1224.
Read now
Read now
Articles from other publishers (53)
Maja Ranković, Anka Jevremović, Aleksandra Janošević Ležaić, Aleksandar Arsenijević, Jelena Rupar, Vladimir Dobričić, Bojana Nedić Vasiljević, Nemanja Gavrilov, Danica Bajuk-Bogdanović & Maja Milojević-Rakić. (2023) Can Zeolite-Supporting Acridines Boost Their Anticancer Performance?. Journal of Functional Biomaterials 14:3, pages 173.
Crossref
Crossref
Asimina Zisi, Jiri Bartek & Mikael S. Lindström. (2022) Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward. Cancers 14:9, pages 2126.
Crossref
Crossref
Makhan Kumar & Angshuman Sarkar. (2022) Repurposing of Anti-Malarial Drug Quinacrine for Cancer Treatment: A Review. Scientia Pharmaceutica 90:1, pages 12.
Crossref
Crossref
Rafaela S. Guimarães, Carolina F. Rodrigues, Natanael Fernandes, Duarte de Melo-Diogo, Paula Ferreira, Ilídio J. Correia & André F. Moreira. (2021) Combinatorial delivery of doxorubicin and acridine orange by gold core silica shell nanospheres functionalized with poly(ethylene glycol) and 4-methoxybenzamide for cancer targeted therapy. Journal of Inorganic Biochemistry 219, pages 111433.
Crossref
Crossref
Biswajit Das & Chanakya N. Kundu. (2021) Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle. Anti-Cancer Agents in Medicinal Chemistry 21:4, pages 416-427.
Crossref
Crossref
Arthur Winer, Crystal S. Denlinger, Namrata Vijayvergia, Steven J. Cohen, Igor Astaturov, Efrat Dotan, Jean-Nicolas Gallant, Edward W. Wang, Miriam Kunkel, Bora Lim, Harold A. Harvey, Jeffrey Sivik, Kenneth Korzekwa, Karen Ruth, Kevin White, Harry S. Cooper, Eric A. Ross, Lanlan Zhou & Wafik S. El-Deiry. (2021) First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer. Clinical Colorectal Cancer 20:1, pages e43-e52.
Crossref
Crossref
Soda Prameela & Fazlur‐Rahman Nawaz Khan. (2020)
Ir(I)‐Catalyzed Synthesis of (
E
)‐4‐Benzylidenylacridines and (
E
)‐2‐Styrylquinoline‐3‐carboxamide through Sequential Suzuki–Miyaura Coupling, Dehydrogenative Friedländer Reaction, and sp
3
‐C–H Activation
. European Journal of Organic Chemistry 2020:33, pages 5394-5410.
Crossref
Crossref
Rui Liang, Yuanfei Yao, Guangyu Wang, Er Yue, Guangchao Yang, Xiuying Qi, Yang Wang, Ling Zhao, Tongsen Zheng, Yanqiao Zhang & Edward Wenge Wang. (2020) Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL. Frontiers in Oncology 10.
Crossref
Crossref
Swathi Veeroju, Argen Mamazhakypov, Nabham Rai, Baktybek Kojonazarov, Valerie Nadeau, Sandra Breuils-Bonnet, Ling Li, Norbert Weissmann, Susanne Rohrbach, Steve Provencher, Sébastien Bonnet, Werner Seeger, Ralph Schermuly & Tatyana Novoyatleva. (2020) Effect of p53 activation on experimental right ventricular hypertrophy. PLOS ONE 15:6, pages e0234872.
Crossref
Crossref
Hongru Yan, Anning Bian, Xiaoge Gao, Huiqin Li, Zetian Chen & Xiangye Liu. (2018) Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine. Future Oncology 14:15, pages 1511-1520.
Crossref
Crossref
Asanda C. Matsheku, Marian Y.-H. Chen, Sandra Jordaan, Sharon Prince, Gregory S. Smith & Banothile C.E. Makhubela. (2017)
Acridine-containing Ru
II
, Os
II
, Rh
III
and Ir
III
Half-Sandwich Complexes: Synthesis, Structure and Antiproliferative Activity
. Applied Organometallic Chemistry 31:12, pages e3852.
Crossref
Crossref
Shujun Yang, Lixia Sheng, Kaihong Xu, Yi Wang, Huiling Zhu, Ping Zhang, Qitian Mu & Guifang Ouyang. (2017) Anticancer effect of quinacrine on diffuse large B‑cell lymphoma via inhibition of MSI2‑NUMB signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Eleftheria Kalogera, Debarshi Roy, Ashwani Khurana, Susmita Mondal, Amy L. Weaver, Xiaoping He, Sean C. Dowdy & Viji Shridhar. (2017) Quinacrine in endometrial cancer: Repurposing an old antimalarial drug. Gynecologic Oncology 146:1, pages 187-195.
Crossref
Crossref
Shun Li, Yi Zhang, Qingyong Liu, Qingli Zhao, Liuyu Xu, Shengliang Huang, Shiming Huang & Xuebin Wei. (2017) Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest. Oncology Letters 13:6, pages 4453-4458.
Crossref
Crossref
Yuan-Chin Lee, Ying-Jung Chen, Chia-Hui Huang & Long-Sen Chang. (2016) Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1. Apoptosis 22:3, pages 406-420.
Crossref
Crossref
Jia Yu, Xiaoqing Zhao, Nanmengzi Zhang, Chaoqun You, Gang Yao, Jin Zhu, Liang Xu & Baiwang Sun. (2017) Identification of novel 3-nitroacridines as autophagy inducers in gastric cancer cells. New Journal of Chemistry 41:10, pages 4087-4095.
Crossref
Crossref
Włodzimierz Korohoda, Anna Hapek, Monika Pietrzak, Damian Ryszawy & Zbigniew Madeja. (2016) 9-AAA inhibits growth and induces apoptosis in human melanoma A375 and rat prostate adenocarcinoma AT-2 and Mat-LyLu cell lines but does not affect the growth and viability of normal fibroblasts. Oncology Letters 12:5, pages 4125-4132.
Crossref
Crossref
Heng-Hong Li. 2016. Toxicogenomics in Predictive Carcinogenicity. Toxicogenomics in Predictive Carcinogenicity
39
75
.
Goutam Karan, Huaiyu Wang, Amit Chakrabarti, Sukanya Karan, Zhigang Liu, Zhiqiang Xia, Mahesh Gundluru, Stephen Moreton, Yogen Saunthararajah, Mark W. Jackson, Mukesh K. Agarwal & David N. Wald. (2016) Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53. Molecular Cancer Therapeutics 15:4, pages 574-582.
Crossref
Crossref
Ashwani Khurana, Debarshi Roy, Eleftheria Kalogera, Susmita Mondal, Xuyang Wen, Xiaoping He, Sean Dowdy & Viji Shridhar. (2015) Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth. Oncotarget 6:34, pages 36354-36369.
Crossref
Crossref
Jung-Jung Changchien, Ying-Jung Chen, Chia-Hui Huang, Tian-Lu Cheng, Shinne-Ren Lin & Long-Sen Chang. (2015) Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression. Toxicology and Applied Pharmacology 284:1, pages 33-41.
Crossref
Crossref
Wei Ju, Meili Zhang, Michael Petrus, Michiyuki Maeda, Cynthia A Pise-Masison & Thomas A Waldmann. (2014) Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia. Retrovirology 11:1.
Crossref
Crossref
Lucia Morgado-Palacin, Susana Llanos, Manuel Urbano-Cuadrado, Carmen Blanco-Aparicio, Diego Megias, Joaquín Pastor & Manuel Serrano. (2014) Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway. Carcinogenesis 35:12, pages 2822-2830.
Crossref
Crossref
Pei-Jung Wu, Wu-Hsiung Wu, Tzu-Chi Chen, Kuan-Ting Lin, Jin-Mei Lai, Chi-Ying F. Huang & Feng-Sheng Wang. (2014) Reconstruction and analysis of a signal transduction network using HeLa cell protein–protein interaction data. Journal of the Taiwan Institute of Chemical Engineers 45:6, pages 2835-2842.
Crossref
Crossref
Wen-Hsin Liu, Ying-Jung Chen, Jen-Hung Chien & Long-Sen Chang. (2014) Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells. Journal of Cellular Physiology 229:5, pages 588-598.
Crossref
Crossref
Chenghu Qin, Jinchao Feng, Shouping Zhu, Xibo Ma, Jianghong Zhong, Ping Wu, Zhengyu Jin & Jie Tian. (2014) Recent advances in bioluminescence tomography: methodology and system as well as application. Laser & Photonics Reviews 8:1, pages 94-114.
Crossref
Crossref
Marcio C. Bajgelman, Ruan F.V. Medrano, Anna Carolina P.V. Carvalho & Bryan E. Strauss. (2013) AAVPG: A vigilant vector where transgene expression is induced by p53. Virology 447:1-2, pages 166-171.
Crossref
Crossref
M. Zulfiquer Hossain, Samuel F. Gilbert, Kalpesh Patel, Soma Ghosh, Anil K. Bhunia & Scott E. Kern. (2013) Biological clues to potent DNA-damaging activities in food and flavoring. Food and Chemical Toxicology 55, pages 557-567.
Crossref
Crossref
Wen-Hsin Liu, Yeh-Long Chen & Long-Sen Chang. (2012) CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability. The International Journal of Biochemistry & Cell Biology 44:12, pages 2212-2222.
Crossref
Crossref
Misol Ahn, Sina Ghaemmaghami, Yong Huang, Puay-Wah Phuan, Barnaby C. H. May, Kurt Giles, Stephen J. DeArmond & Stanley B. Prusiner. (2012) Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter. PLoS ONE 7:7, pages e39112.
Crossref
Crossref
Xiaoyang Wu, Yunliang Wang, Hongwei Wang, Qiang Wang, Lin Wang, Jingcheng Miao, Fengmei Cui & Jinzhi Wang. (2012) Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901. Current Therapeutic Research 73:1-2, pages 52-64.
Crossref
Crossref
Reza Ehsanian, Carter Van Waes & Stephan M Feller. (2011) Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers. Cell Communication and Signaling 9:1.
Crossref
Crossref
Hideko Sone & Hiromi Akanuma. 2011. Oxidative Stress in Vertebrates and Invertebrates. Oxidative Stress in Vertebrates and Invertebrates
175
194
.
Grzegorz Cholewiński, Krystyna Dzierzbicka & Aleksander M. Kołodziejczyk. (2011) Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. Pharmacological Reports 63:2, pages 305-336.
Crossref
Crossref
Drew D. Dudgeon, Sunita Shinde, Yun Hua, Tong Ying Shun, John S. Lazo, Christopher J. Strock, Kenneth A. Giuliano, D. Lansing Taylor, Patricia A. Johnston & Paul A. Johnston. (2010) Implementation of a 220,000-Compound HCS Campaign to Identify Disruptors of the Interaction between p53 and hDM2 and Characterization of the Confirmed Hits. SLAS Discovery 15:7, pages 766-782.
Crossref
Crossref
Drew D. DudgeonSunita N. ShindeTong Ying ShunJohn S. LazoChristopher J. StrockKenneth A. GiulianoD. Lansing TaylorPatricia A. JohnstonPaul A. Johnston. (2010) Characterization and Optimization of a Novel Protein–Protein Interaction Biosensor High-Content Screening Assay to Identify Disruptors of the Interactions Between p53 and hDM2. ASSAY and Drug Development Technologies 8:4, pages 437-458.
Crossref
Crossref
Michael P. Dickens, Ross Fitzgerald & Peter M. Fischer. (2010) Small-molecule inhibitors of MDM2 as new anticancer therapeutics. Seminars in Cancer Biology 20:1, pages 10-18.
Crossref
Crossref
Frank Erdmann, Matthias Weiwad, Susann Kilka, Magdalena Karanik, Michael Pätzel, Ria Baumgrass, Jürgen Liebscher & Gunter Fischer. (2010) The Novel Calcineurin Inhibitor CN585 Has Potent Immunosuppressive Properties in Stimulated Human T Cells. Journal of Biological Chemistry 285:3, pages 1888-1898.
Crossref
Crossref
Chao Lu & Wafik S. El-Deiry. (2009) Targeting p53 for enhanced radio- and chemo-sensitivity. Apoptosis 14:4, pages 597-606.
Crossref
Crossref
Ha Lim Oh, Haeyoung Lim, Youl-Hee Cho, Hyun Chul Koh, Hojung Kim, Yoongho Lim & Chul-Hoon Lee. (2009) HY251, a novel cell cycle inhibitor isolated from Aralia continentalis, induces G1 phase arrest via p53-dependent pathway in HeLa cells. Bioorganic & Medicinal Chemistry Letters 19:3, pages 959-961.
Crossref
Crossref
Ella Kim, Alf Giese & Wolfgang Deppert. (2009) Wild-type p53 in cancer cells: When a guardian turns into a blackguard. Biochemical Pharmacology 77:1, pages 11-20.
Crossref
Crossref
Anwesha Dey, Vinay Tergaonkar & David P. Lane. (2008) Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways. Nature Reviews Drug Discovery 7:12, pages 1031-1040.
Crossref
Crossref
Emily A. Bassett, Wenge Wang, Farzan Rastinejad & Wafik S. El-Deiry. (2008) Structural and Functional Basis for Therapeutic Modulation of p53 Signaling. Clinical Cancer Research 14:20, pages 6376-6386.
Crossref
Crossref
Jürgen K. Willmann, Nicholas van Bruggen, Ludger M. Dinkelborg & Sanjiv S. Gambhir. (2008) Molecular imaging in drug development. Nature Reviews Drug Discovery 7:7, pages 591-607.
Crossref
Crossref
Sang-ki Park, Hyerim Kang & Chul-Hoon Kwon. (2008) Caspase-dependent cell death mediates potent cytotoxicity of sulfide derivatives of 9-anilinoacridine. Anti-Cancer Drugs 19:4, pages 381-389.
Crossref
Crossref
Tiziana Rossi, Andrea Coppi, Elisa Bruni, Miriam Sgobba, Gianluca Degliesposti & Giulio Rastelli. (2008) In vitro Effects ofPlasmodium falciparum Dihydrofolate Reductase Inhibitors on Normal and Cancer Cell Proliferation. ChemMedChem 3:3, pages 421-424.
Crossref
Crossref
Wenge Wang & Wafik S El-Deiry. (2008) Restoration of p53 to limit tumor growth. Current Opinion in Oncology 20:1, pages 90-96.
Crossref
Crossref
Philipp Mayer-Kuckuk & Debabrata Banerjee. 2008. Cancer Imaging. Cancer Imaging
3
14
.
Xiuwei Tang, Yucui Zhu, Lydia Han, Arianna L. Kim, Levy Kopelovich, David R. Bickers & Mohammad Athar. (2007) CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice. Journal of Clinical Investigation 117:12, pages 3753-3764.
Crossref
Crossref
Jay Friedman, Liesl Nottingham, Praveen Duggal, Francisco G. Pernas, Bin Yan, Xin Ping Yang, Zhong Chen & Carter Van Waes. (2007) Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer. Clinical Cancer Research 13:22, pages 6568-6578.
Crossref
Crossref
Heng-Hong Li, Jiri Aubrecht & Albert J. FornaceJr.Jr.. (2007) Toxicogenomics: Overview and potential applications for the study of non-covalent DNA interacting chemicals. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 623:1-2, pages 98-108.
Crossref
Crossref
Min Kyoung Kim, Ha Lim Oh, Bu-Young Choi, Haeyoung Lim, Youl-Hee Cho & Chul-Hoon Lee. (2007) CR229, a novel derivative of β-carbolin-1-one, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation. Cancer Science 98:9, pages 1402-1407.
Crossref
Crossref
Wafik S. El-Deiry, Caroline C. Sigman & Gary J. Kelloff. (2006) Imaging and Oncologic Drug Development. Journal of Clinical Oncology 24:20, pages 3261-3273.
Crossref
Crossref